| |
| | Rules 2005 - Schedules of Controlled Substances: Placement of Zopiclone Into Schedule IV |
 | | Enclosed with the January 18, 2005, letter was a document prepared by the FDA entitled, ``Basis for the Recommendation for Control of Zopiclone and its Optical Isomers in Schedule IV of the Controlled Substances Act (CSA).'' The document contained a review of the factors which the CSA requires the Secretary to consider (21 U.S.C. 811(b)). |
 | | Zopiclone is subject to Schedule III-V security requirements and must be manufactured, distributed and stored in accordance with § § 1301.71, 1301.72(b), (c), and (d), 1301.73, 1301.74, 1301.75(b) and (c), 1301.76, and 1301.77 of Title 21 of the Code of Federal Regulations after April 4, 2005. |
 | | All importation and exportation of zopiclone must be in compliance with part 1312 of Title 21 of the Code of Federal Regulations after April 4, 2005. |
| www.deadiversion.usdoj.gov /fed_regs/rules/2005/fr0404.htm (1639 words) |
|